rs55730247

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_080680.3(COL11A2):​c.2484+13delG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0871 in 1,577,118 control chromosomes in the GnomAD database, including 10,475 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.098 ( 1219 hom., cov: 30)
Exomes 𝑓: 0.086 ( 9256 hom. )

Consequence

COL11A2
NM_080680.3 intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.49

Publications

5 publications found
Variant links:
Genes affected
COL11A2 (HGNC:2187): (collagen type XI alpha 2 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. It is located on chromosome 6 very close to but separate from the gene for retinoid X receptor beta. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Proteolytic processing of this type XI chain produces PARP, a proline/arginine-rich protein that is an amino terminal domain. Mutations in this gene are associated with type III Stickler syndrome, otospondylomegaepiphyseal dysplasia (OSMED syndrome), Weissenbacher-Zweymuller syndrome, autosomal dominant non-syndromic sensorineural type 13 deafness (DFNA13), and autosomal recessive non-syndromic sensorineural type 53 deafness (DFNB53). Alternative splicing results in multiple transcript variants. A related pseudogene is located nearby on chromosome 6. [provided by RefSeq, Jul 2009]
COL11A2 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 13
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • nonsyndromic genetic hearing loss
    Inheritance: AD, AR Classification: DEFINITIVE, MODERATE Submitted by: ClinGen
  • otospondylomegaepiphyseal dysplasia, autosomal dominant
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive nonsyndromic hearing loss 53
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • otospondylomegaepiphyseal dysplasia
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • otospondylomegaepiphyseal dysplasia, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • fibrochondrogenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 6-33174151-AC-A is Benign according to our data. Variant chr6-33174151-AC-A is described in ClinVar as Benign. ClinVar VariationId is 262308.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.5 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL11A2NM_080680.3 linkc.2484+13delG intron_variant Intron 32 of 65 ENST00000341947.7 NP_542411.2 P13942A0A0C4DFS1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL11A2ENST00000341947.7 linkc.2484+13delG intron_variant Intron 32 of 65 5 NM_080680.3 ENSP00000339915.2 A0A0C4DFS1
COL11A2ENST00000374708.8 linkc.2226+13delG intron_variant Intron 30 of 63 5 ENSP00000363840.4 Q4VXY6
COL11A2ENST00000361917.6 linkc.1056+13delG intron_variant Intron 19 of 23 5 ENSP00000355123.2 H0YIS1
COL11A2ENST00000477772.1 linkn.272+2857delG intron_variant Intron 5 of 8 2

Frequencies

GnomAD3 genomes
AF:
0.0980
AC:
14398
AN:
146962
Hom.:
1208
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.102
Gnomad AMI
AF:
0.0536
Gnomad AMR
AF:
0.0866
Gnomad ASJ
AF:
0.0442
Gnomad EAS
AF:
0.516
Gnomad SAS
AF:
0.0929
Gnomad FIN
AF:
0.0891
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.0711
Gnomad OTH
AF:
0.114
GnomAD2 exomes
AF:
0.105
AC:
21532
AN:
204660
AF XY:
0.102
show subpopulations
Gnomad AFR exome
AF:
0.0960
Gnomad AMR exome
AF:
0.0762
Gnomad ASJ exome
AF:
0.0450
Gnomad EAS exome
AF:
0.518
Gnomad FIN exome
AF:
0.0781
Gnomad NFE exome
AF:
0.0679
Gnomad OTH exome
AF:
0.0859
GnomAD4 exome
AF:
0.0860
AC:
122965
AN:
1430048
Hom.:
9256
Cov.:
37
AF XY:
0.0850
AC XY:
60306
AN XY:
709532
show subpopulations
African (AFR)
AF:
0.0945
AC:
3063
AN:
32420
American (AMR)
AF:
0.0781
AC:
3308
AN:
42336
Ashkenazi Jewish (ASJ)
AF:
0.0467
AC:
1194
AN:
25570
East Asian (EAS)
AF:
0.522
AC:
19730
AN:
37814
South Asian (SAS)
AF:
0.0798
AC:
6571
AN:
82362
European-Finnish (FIN)
AF:
0.0767
AC:
3894
AN:
50766
Middle Eastern (MID)
AF:
0.0706
AC:
403
AN:
5706
European-Non Finnish (NFE)
AF:
0.0725
AC:
79280
AN:
1093898
Other (OTH)
AF:
0.0933
AC:
5522
AN:
59176
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
6441
12882
19324
25765
32206
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3184
6368
9552
12736
15920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0980
AC:
14416
AN:
147070
Hom.:
1219
Cov.:
30
AF XY:
0.100
AC XY:
7194
AN XY:
71734
show subpopulations
African (AFR)
AF:
0.101
AC:
4010
AN:
39528
American (AMR)
AF:
0.0866
AC:
1286
AN:
14848
Ashkenazi Jewish (ASJ)
AF:
0.0442
AC:
150
AN:
3394
East Asian (EAS)
AF:
0.516
AC:
2599
AN:
5036
South Asian (SAS)
AF:
0.0932
AC:
425
AN:
4562
European-Finnish (FIN)
AF:
0.0891
AC:
900
AN:
10100
Middle Eastern (MID)
AF:
0.110
AC:
32
AN:
292
European-Non Finnish (NFE)
AF:
0.0710
AC:
4715
AN:
66364
Other (OTH)
AF:
0.122
AC:
251
AN:
2050
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
604
1208
1811
2415
3019
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
160
320
480
640
800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0718
Hom.:
80
Asia WGS
AF:
0.239
AC:
829
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jan 08, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Otospondylomegaepiphyseal dysplasia, autosomal dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Otospondylomegaepiphyseal dysplasia, autosomal recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fibrochondrogenesis 1 Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Stickler Syndrome, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55730247; hg19: chr6-33141928; COSMIC: COSV107403544; COSMIC: COSV107403544; API